TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Accrual Picking Up, Still “Nothing To Write Home About;” Unfunded MDs ‘Subsidizing Entire Program” June 3, 1988
TCL Archive Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy June 27, 2014
